K. V. Rangareddy, India

Sathyamangalam Swaminathan

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Sun Pharmaceutical Industries Limited. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sathyamangalam Swaminathan. Retrieved from https://idiyas.com/inventor/sathyamangalam-swaminathan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 16.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sathyamangalam Swaminathan: Innovator in Anti-Dengue Pharmaceutical Compositions

Introduction

Sathyamangalam Swaminathan is a notable inventor based in K. V. Rangareddy, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-dengue treatments. His innovative work has the potential to impact public health positively.

Latest Patents

Sathyamangalam Swaminathan holds a patent related to the anti-dengue activity of specific extracts. The patent describes pharmaceutical compositions comprising these extracts and outlines processes for their preparation. This invention is crucial in the fight against dengue fever, a disease that poses a significant health risk in many regions.

Career Highlights

Swaminathan is associated with Sun Pharmaceutical Industries Limited, a leading global pharmaceutical company. His role in this organization allows him to contribute to the development of effective medical solutions. His expertise in pharmaceutical sciences has been instrumental in advancing the company's research initiatives.

Collaborations

Some of his notable coworkers include Pradip Kumar Bhatnagar and Chandra Kant Katiyar. Their collaboration fosters a dynamic environment for innovation and research within the company.

Conclusion

Sathyamangalam Swaminathan's work in developing anti-dengue pharmaceutical compositions highlights his commitment to improving public health. His contributions, along with his collaborations, continue to pave the way for advancements in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…